RAMMF - RAMM Pharma to acquire 100% of European cannabis company Canapar

RAMM Pharma ([[RAMMF]]) has entered into a definitive agreement to purchase 100% of European cannabis company Canapar for a total purchase price of about $26.2M.The deal is to purchase all shares of Canapar that RAMM does not currently own in exchange for about 21.9M RAMM shares at a deemed value of $1.20/share.RAMM initially acquired a 49% stake in Canapar in December 2020 and invested $3M in the company through a convertible note in January 2021.The deal will give RAMM access to Canapar supply contracts in place including a five-year agreement for 38.5M euros (7.7 million euros per year) with a leading ingredient company for full spectrum CBD oil.

For further details see:

RAMM Pharma to acquire 100% of European cannabis company Canapar